Technical Analysis for PTCT - PTC Therapeutics, Inc.

Grade Last Price % Change Price Change
D 29.01 -1.83% -0.54
PTCT closed down 1.83 percent on Monday, March 18, 2024, on 69 percent of normal volume.
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Down

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Spinning Top Other 0.00%
MACD Bearish Signal Line Cross Bearish -1.83%
Crossed Above 20 DMA Bullish -1.83%
Pocket Pivot Bullish Swing Setup -1.83%
Inside Day Range Contraction -1.83%
Fell Below 20 DMA Bearish 0.42%
Multiple of Ten Bearish Other 0.42%
Wide Bands Range Expansion 0.42%
Gapped Down Weakness 0.42%

   Recent Intraday Alerts

Alert Time
Down 3% about 20 hours ago
Fell Below Previous Day's Low about 20 hours ago
Down 2 % about 20 hours ago
Fell Below 20 DMA about 21 hours ago
20 DMA Support about 21 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

PTC Therapeutics, Inc. Description

PTC Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of orally administered and proprietary small-molecule drugs for patients living with serious and life-threatening conditions, including genetic and neuromuscular disorders, cancer, and infectious diseases. Its approach includes post-transcriptional control, RNA biology, and gene expression modulation by small-molecules. The company has strategic alliances with AstraZeneca; Celgene Corporation; Cystic Fibrosis Foundation; Genzyme Corporation; Gilead; Muscular Dystrophy Association; Merck & Co., Inc.; Parent Project Muscular Dystrophy; Pfizer Inc.; Roche; Spinal Muscular Atrophy Foundation; and Wellcome Trust. PTC Therapeutics, Inc. was founded in 1998 and is based in South Plainfield, New Jersey.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Biology Infectious Diseases Neurological Disorders Gene Expression Dystrophy Cystic Fibrosis Muscular Dystrophy Neurodegenerative Disorders Transcription Spinal Muscular Atrophy Genzyme Neuromuscular Disorders

Is PTCT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 59.75
52 Week Low 17.53
Average Volume 1,005,129
200-Day Moving Average 30.76
50-Day Moving Average 27.81
20-Day Moving Average 29.27
10-Day Moving Average 30.47
Average True Range 1.62
RSI (14) 50.50
ADX 29.39
+DI 19.00
-DI 15.67
Chandelier Exit (Long, 3 ATRs) 28.04
Chandelier Exit (Short, 3 ATRs) 29.99
Upper Bollinger Bands 33.15
Lower Bollinger Band 25.39
Percent B (%b) 0.47
BandWidth 26.52
MACD Line 0.82
MACD Signal Line 0.99
MACD Histogram -0.1734
Fundamentals Value
Market Cap 2.19 Billion
Num Shares 75.5 Million
EPS -8.82
Price-to-Earnings (P/E) Ratio -3.29
Price-to-Sales 2.45
Price-to-Book 1743.27
PEG Ratio 0.81
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 30.92
Resistance 3 (R3) 30.98 30.41 30.60
Resistance 2 (R2) 30.41 29.92 30.38 30.49
Resistance 1 (R1) 29.71 29.63 29.43 29.65 30.39
Pivot Point 29.14 29.14 29.00 29.11 29.14
Support 1 (S1) 28.44 28.65 28.16 28.38 27.63
Support 2 (S2) 27.87 28.36 27.84 27.53
Support 3 (S3) 27.17 27.87 27.42
Support 4 (S4) 27.11